Thyroid Cancer in the Pediatric Population

Vera A Paulson1, Erin R Rudzinski2, Douglas S Hawkins3

  • 1Dept. of Laboratory Medicine, University of Washington Medical Center, 1959 NE Pacific St, Box 357110, Seattle, WA 98105, USA. vpauls@uw.edu.

Genes
|September 22, 2019
PubMed

Insights

Pediatric thyroid cancer differs from adult types, often presenting at advanced stages with unique molecular features like gene fusions in papillary thyroid carcinoma. Recognizing these distinctions is key for diagnosis and treatment.

Area of Science:

  • Pediatric Oncology
  • Molecular Pathology
  • Endocrinology

Background:

  • Thyroid cancer is rare in children but presents with distinct clinical and molecular profiles compared to adults.
  • Pediatric thyroid cancers often exhibit more aggressive, advanced-stage disease at diagnosis.

Purpose of the Study:

  • To highlight the unique clinicopathologic and molecular characteristics of pediatric thyroid cancer.
  • To emphasize the importance of understanding these differences for diagnostic and therapeutic strategies.

Main Methods:

  • Review of clinical, pathological, and molecular data from pediatric thyroid cancer cases.
  • Comparison of pediatric thyroid cancer features with those observed in adult populations.
  • Analysis of specific molecular alterations, such as gene fusions in papillary thyroid carcinoma.

Main Results:

  • Papillary thyroid carcinoma, comprising ~90% of pediatric cases, shows a high frequency of gene fusions.
  • These gene fusions are linked to specific histologic subtypes, advanced extrathyroidal extension, and potential targeted therapy options.
  • Distinct features are also noted in pediatric follicular and medullary thyroid carcinomas, though less studied.

Conclusions:

  • The unique molecular landscape of pediatric thyroid cancer, particularly gene fusions in papillary subtypes, significantly impacts disease presentation and treatment.
  • Understanding these differences is crucial for selecting appropriate diagnostic tests and guiding therapeutic recommendations in children.

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.2K